At WCG, we enter 2021 with great anticipation for a new decade of tremendous opportunities for advancing human health.
2020 has been a year like no other. As we look back on the impact that the COVID-19 pandemic has had on the clinical research industry, we can all take pride in our collective contribution to the development of vaccines, therapies and diagnostics that combat this virus.
Looking ahead to 2021, we have a new outlook on how we can conduct clinical research with a new-found capacity for flexibility, collaboration, and a focus on the importance of both patient-centric research practices and diversity. In our 2021 prospectus, 23 industry experts from WCG share the important shifts, trends, regulations, and priorities that will inform clinical trial development in 2021 and beyond.